We aimed to investigate whether the reduced incretin effect observed in patients with type 2 diabetes is a primary event in the pathogenesis of type 2 diabetes or a consequence of the diabetic state.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback